RMDI
EW icon

R.M. Davis Inc’s Edwards Lifesciences EW Stock Holding History

R.M. Davis Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,785
Closed -$212K – 264
2023
Q4 		$212K Buy
+2,785
New +$194K ﹤0.01% 257
2023
Q3 		– Sell
-2,889
Closed -$273K – 273
2023
Q2 		$273K Sell
2,889
-876
-23% -$76.1K 0.01% 246
2023
Q1 		$311K Sell
3,765
-19
-0.5% -$1.49K 0.01% 224
2022
Q4 		$282K Buy
3,784
+180
+5% +$13.9K 0.01% 230
2022
Q3 		$298K Buy
3,604
+729
+25% +$70.1K 0.01% 223
2022
Q2 		$273K Hold
2,875
– – 0.01% 225
2022
Q1 		$338K Buy
2,875
+175
+6% +$19.6K 0.01% 218
2021
Q4 		$350K Sell
2,700
-57
-2% -$6.65K 0.01% 215
2021
Q3 		$312K Buy
2,757
+57
+2% +$6.51K 0.01% 218
2021
Q2 		$280K Sell
2,700
-24
-0.9% -$2.26K 0.01% 230
2021
Q1 		$228K Hold
2,724
– – 0.01% 245
2020
Q4 		$249K Buy
+2,724
New +$226K 0.01% 241

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

R.M. Davis Inc's EW Position: Q1 2024 in Review

R.M. Davis Inc sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 2,785 shares — an estimated $212K sold.

R.M. Davis Inc first reported a position in EW in Q4 2020 and held it in 12 quarters. The position peaked at $350K in Q4 2021. 1,282 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • R.M. Davis Inc reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • R.M. Davis Inc sold 2,785 Edwards Lifesciences shares in Q1 2024, an estimated $212K.
  • R.M. Davis Inc first reported a position in Edwards Lifesciences in Q4 2020 and held it in 12 quarters.
  • R.M. Davis Inc's Edwards Lifesciences position peaked at $350K in Q4 2021.
  • 1,282 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on R.M. Davis Inc's 13F filing for Q1 2024, filed 10 May 2024.